Literature DB >> 19913155

Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.

Susan Higginbotham.   

Abstract

Contraceptive failure is the primary cause of unintended pregnancy in the United States. With obesity rates at epidemic proportions, any association between obesity and strategies that prevent undesired pregnancies constitutes a significant public health and economic concern. Unfortunately, the relationship between obesity and contraception has not been extensively studied. Evidence from several epidemiological studies suggests that obesity may increase failure of some hormonal contraceptives resulting in unplanned pregnancies. Obesity may make procedure-dependent contraceptive methods (i.e., sterilization and intrauterine devices) more technically challenging for the provider to perform. Hormonal contraceptives, on the whole, do not appear to adversely affect body weight and provide important noncontraceptive benefits (i.e., cancer protection). Some surgical interventions to treat bariatric issues may compromise the efficacy of orally dosed contraceptive methods. Overall, the Society of Family Planning strongly encourages the use of both hormonal and nonhormonal methods of contraception in obese women desiring pregnancy prevention with very few restrictions. Further studies are needed to determine the interrelationship between obesity and contraception. In addition, future contraceptive efficacy studies need to include women of differing BMIs to better reflect the population of women using these methods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913155     DOI: 10.1016/j.contraception.2009.08.001

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

Review 1.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen-Mok; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 2.  [Gender Obesity Report--Influence of obesity on Reproduction and Pregnancy].

Authors:  Jürgen Harreiter; Alexandra Kautzky-Willer
Journal:  Wien Med Wochenschr       Date:  2015-12-09

3.  Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.

Authors:  Daniel Grossman; Kari White; Kristine Hopkins; Jon Amastae; Michele Shedlin; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

Review 4.  Obesity and hormonal contraceptive efficacy.

Authors:  Jennifer A Robinson; Anne E Burke
Journal:  Womens Health (Lond)       Date:  2013-09

Review 5.  Safety and efficacy of contraception--Why should the obese woman be any different?

Authors:  Maria I Rodriguez; Alison B Edelman
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

6.  Progestin-only contraceptive pill use among women in the United States.

Authors:  Kelli Stidham Hall; James Trussell; Eleanor Bimla Schwarz
Journal:  Contraception       Date:  2012-06-06       Impact factor: 3.375

Review 7.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2013-07-02

8.  Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.

Authors:  Hanna Xu; Jennifer A Wade; Jeffrey F Peipert; Qiuhong Zhao; Tessa Madden; Gina M Secura
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

9.  Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.

Authors:  Alison B Edelman; Ganesh Cherala; Myrna Y Munar; Barent Dubois; Martha McInnis; Frank Z Stanczyk; Jeffrey T Jensen
Journal:  Contraception       Date:  2012-11-12       Impact factor: 3.375

10.  Contraception, Menstruation, and Sexuality after Bariatric Surgery: a Prospective Cohort Study.

Authors:  Julie Luyssen; Goele Jans; Annick Bogaerts; Dries Ceulemans; Christophe Matthys; Bart Van der Schueren; Matthias Lannoo; Johan Verhaeghe; Luc Lemmens; Lore Lannoo; Jill Shawe; Roland Devlieger
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.